
Precigen Inc PGEN.OQ PGEN.O is expected to show a fall in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025
The Germantown Maryland-based company is expected to report a 53.1% decrease in revenue to $500 thousand from $1.07 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Precigen Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts had risen by about 8.7% in the last three months.
Wall Street's median 12-month price target for Precigen Inc is $6.00, above its last closing price of $1.35.
This summary was machine generated May 9 at 21:24 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)